What Haptoglobin is Used For
Haptoglobin is primarily used as a diagnostic marker to detect and monitor hemolysis (red blood cell destruction), serving as one of the cornerstone laboratory tests alongside LDH and plasma free hemoglobin to identify conditions causing intravascular hemolysis.
Primary Clinical Applications
Detection of Hemolysis
Haptoglobin functions as a general marker of chronic hemolytic anemia 1. When red blood cells break down, free hemoglobin is released into the bloodstream. Haptoglobin binds this free hemoglobin, and its levels drop as it becomes depleted during hemolytic processes. A decreased haptoglobin level signals active hemolysis 2.
Specific Clinical Contexts Where Haptoglobin Testing is Essential
In mechanical circulatory support (VAD patients): A haptoglobin drop can signal hemolysis and pump thrombosis, though it may already be decreased due to subclinical hemolysis in a normally functioning VAD 2. The test is used alongside LDH (>2.5 times upper limit of normal) and plasma free hemoglobin (>40 mg/dL) as part of the diagnostic triad for VAD thrombosis 2.
In emergency medicine presentations: Any case of anemia plus thrombocytopenia should always prompt determination of haptoglobin, indirect bilirubin, and LDH levels 3. This combination helps distinguish between:
- Atypical hemolytic uremic syndrome (aHUS)
- Thrombotic thrombocytopenic purpura (TTP)
- Secondary causes of hemolysis
In hereditary hemolytic conditions: Haptoglobin is part of the first-level investigations for pyruvate kinase deficiency, alongside complete blood count, RBC morphology, and other hemolysis markers (reticulocyte count, LDH, unconjugated bilirubin) 1.
Important Clinical Caveats
Limitations as a Hemolysis Marker
- Less sensitive than LDH for detecting device thrombosis, with results taking several days to be delivered 2
- May be already low at baseline in patients with subclinical hemolysis (e.g., normally functioning VADs), reducing its diagnostic utility 2
- Limited clinical value in children under 13-15 years, as haptoglobin levels are often naturally low and may fall below assay detection thresholds 4
Interpretation Considerations
Haptoglobin is an acute-phase protein, meaning its concentration changes in various pathological states beyond hemolysis 5. It is synthesized mainly in the liver and lungs, so hepatic dysfunction can affect baseline levels.
Emerging Therapeutic Applications
While primarily a diagnostic marker, exogenous haptoglobin administration is being investigated as a treatment for hemolysis-related complications. Recent evidence shows:
- Significant reduction in postoperative acute kidney injury in cardiac surgery patients (adjusted OR = 0.54) 6
- Lower plasma-free hemoglobin levels at 1 hour (SMD -11.28) and 24 hours (SMD -2.65) after infusion 7
- Reduced incidence of acute kidney injury (OR 0.64) 7
- No reported adverse events associated with haptoglobin administration 7
However, therapeutic benefit appears context-dependent, with no demonstrated benefit in severe burn patients 6.
Practical Testing Algorithm
When suspecting hemolysis, order haptoglobin as part of a panel:
- Mandatory concurrent tests: LDH, plasma free hemoglobin, indirect bilirubin, reticulocyte count
- Additional context-specific tests: Complete blood count, direct Coombs test (to exclude immune-mediated hemolysis), peripheral blood smear for schistocytes
- In specific populations: ADAMTS13 activity if TTP suspected, stool testing for VTEC if STEC-HUS considered 3
Low haptoglobin alone is insufficient for diagnosis—it must be interpreted alongside clinical presentation and other hemolysis markers to determine the underlying cause and guide management 2, 1, 3.